ABU DHABI, UAE, May 28, 2025 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that target the innate immune system, announces that CEO Dr. David Bearss will serve as keynote speaker at the Med Investment Forum 2025. The event will take…
